| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/28/1999 | US6008342 A dna encoding an immunogenic polypeptide; coccidiosis vaccines in poultry |
| 12/28/1999 | US6008341 A dna molecule; vaccine to prevent staphylococcus infections, promote wound healing, block adhesion of host plasma and matrix proteins to medical devices after implantation, therapy for sepsis and infections of the heart |
| 12/28/1999 | US6008340 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules |
| 12/28/1999 | US6008339 An oligonucleotide encoding a polypeptide, dor3, that induces dorsal and neural tissue development in vertebrates; therapy and diagnosis of alzheimer's/parkinson's/huntington's chorea, congenital diseases, anticarcinogenic/wound healing agents |
| 12/28/1999 | US6008338 All-trans retinaldehyde binding protein, DNA encoding same, and antibodies thereto |
| 12/28/1999 | US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents |
| 12/28/1999 | US6008336 Compacted nucleic acids and their delivery to cells |
| 12/28/1999 | US6008335 Methods of screening for ulcerative colitis and Crohn's disease |
| 12/28/1999 | US6008329 Method for purifying cholera toxin |
| 12/28/1999 | US6008328 Method for purifying keratinocyte growth factors |
| 12/28/1999 | US6008327 Antibodies to the epstein-barr virus, comprising of viral capsid antigen proteins; diagnosis and therapy for burkitt's lymphoma, nasopharyngeal cancer |
| 12/28/1999 | US6008326 A monospecific antigen protein of haemophililus influenzae; therapy for ear infections, meningitis, pneumonia, and oral diseases |
| 12/28/1999 | US6008325 An antibody specific for a trimeric alpha-homotrimer propeptide; therapy for osteoporosis, rheumatic diseases; anticarcinogenic/antiarthritic agents |
| 12/28/1999 | US6008324 A protein from a plant having a n-glucosidase chain linked by a disulfide bridge to a lectin chain; and interacts with ribosomal rna and inhibits protein sysnthesis; therapy for acquired immune deficiency syndrome; anticarcinogenic agent |
| 12/28/1999 | US6008323 Transdominant negative proto-oncogene |
| 12/28/1999 | US6008322 Stanniocalcin-2 |
| 12/28/1999 | US6008320 Elastase inhibitor and process for preparing the same |
| 12/28/1999 | US6008319 A permeability enhancing peptide that is free of cytokine activity and is joined to a delivery vehicle that targets tumors; therapy for increasing uptake of antitumor agents or tumor imaging agents |
| 12/28/1999 | US6008203 Administering a sialylated lactose carbohydrate compound antitumor agent |
| 12/28/1999 | US6008201 DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 12/28/1999 | US6008198 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same |
| 12/28/1999 | US6008197 Activating the freeze dried denatured cells with a denaturing agent solution; use as promoting bone healing or bone formation in mammal |
| 12/28/1999 | US6008195 Antimicrobial peptides and methods of use |
| 12/28/1999 | US6008194 Human preprotachykinin B |
| 12/28/1999 | US6008193 Methods of using human von Willebrand factor GPIb binding domain polypeptides |
| 12/28/1999 | US6008051 A plasmid with halobacterium dna encoding a polypeptide capable of forming gas vesicles in non-floating escherichia cells; harvesting cells in fermentation and bioremediation as conferring bouyancy to hydrocarbon-degrading bacteria |
| 12/28/1999 | US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease |
| 12/28/1999 | US6008046 Drug and pesticide screening |
| 12/28/1999 | US6008044 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC) |
| 12/28/1999 | US6008039 Polynucleotide encoding a novel purinergic P2U receptor |
| 12/28/1999 | US6008035 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 12/28/1999 | US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents |
| 12/28/1999 | US6008029 A nucleic acid which codes a protein obtained from a coprinus strain; for industrial use in lignin modification, paper strengthening, dye transfer inhibition in detergents, phenol polymerization, juice manufacture and waste water treatment |
| 12/28/1999 | US6008024 An protein which forms an immunological complex with a phosphorylated epitope of an antigen belonging to a paired helical filament-tau protein; diagnosis and therapy for alzheimer's disease |
| 12/28/1999 | US6008022 Human cytokine polypeptide |
| 12/28/1999 | US6008020 Brain-associated inhibitor of tissue-type plasminogen activator |
| 12/28/1999 | US6008018 ELL2, a new member of an ELL family of RNA polymerase II elongation factors |
| 12/28/1999 | US6008017 Human cardiac/brain tolloid-like protein |
| 12/28/1999 | US6008016 Spruce budworm antifreeze proteins, genes and methods of using same |
| 12/28/1999 | US6008015 Glycine transporter |
| 12/28/1999 | US6008014 Method of making lipid metabolic pathway compositions |
| 12/28/1999 | US6008013 A dna which codes for a protein expressed in the lower proliferative or upper hypertrophic zones of long bone and embryonic vertebrae growth plates; therapy and diagnosis of genetic bone defects; antiarthritic agent |
| 12/28/1999 | US6008012 Human somatostatin-like receptor |
| 12/28/1999 | US6008011 A nucleic acid; therapy for osteoporosis, rheumatic diseases; antiproliferative/anticarcinogenic/antiinflammatory agents; wound healing agents; immunosuppressants |
| 12/28/1999 | US6007988 A library of dna sequences which encode zinc finger polypeptide binding motifs for display on viral particles; the dna sequences having random allocation of amino acids; for producing zinc finger molecules |
| 12/28/1999 | US6007986 Methods for anti-addictive narcotic analgesic activity screening |
| 12/28/1999 | US6007981 Modifying target cells making them sensative to a toxin; transforming cells with a nucleotide sequences encoding a receptor that binds cryia toxin of bacillus, culturing cells allowing receptor expression on cell surface |
| 12/28/1999 | US6007980 A method for detecting goodpasture antibodies in a biological fluid sample by mixing fluid sample with a peptide which codes for a human collagen; antibodies in sample binding to peptide in an immunoassay idicates antibodies are present |
| 12/28/1999 | US6007825 Serpulina hyodysenteriae vaccine comprising a tly gene mutant |
| 12/28/1999 | US6007821 Immunosuppression; organ transplants, insulin dependent diabetes |
| 12/28/1999 | US6007820 Purification and characterization of MHC-peptide complexes useful in ameliorating autoimmunity |
| 12/28/1999 | US6007816 Reducing transmigration of lymphocytes through endothelium into lymph node or inflamed synovium by administering monoclonal antibody specifically binding to a hybridized mammalian dna encoded polypeptide |
| 12/28/1999 | US6007815 Immunology |
| 12/28/1999 | US6007806 Vaccinia virus vector comprising a heterologous dna sequence coding for essential region of t antigen, a protein specific to tumors caused by a papilloma virus |
| 12/28/1999 | US6007792 Chelate compounds labeled with technetium-99m, rhenium-186, or rhenium-188; tumor imaging |
| 12/28/1999 | US6006753 Therapy |
| 12/28/1999 | US6006470 Nematicidal proteins |
| 12/28/1999 | CA2223142C Use of the indeterminate gametophyte gene for maize improvement |
| 12/28/1999 | CA2191862C Branched synthetic peptide conjugate |
| 12/28/1999 | CA2151586C Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 12/28/1999 | CA2143163C Peptides derived from a retrovirus of the hiv group, and their use |
| 12/28/1999 | CA2068734C Mutants or variants of bacillus thuringiensis producing high yields of delta endotoxin |
| 12/28/1999 | CA2054843C Novel strains of bacillus thuringiensis |
| 12/28/1999 | CA1340866C Human c3b/c4b receptor (cr1) |
| 12/28/1999 | CA1340863C Domain-modified constant region antibodies |
| 12/28/1999 | CA1340862C Method of producing a human protein and dna-sequence for use when carrying out the method |
| 12/28/1999 | CA1340861C Cysteine-depleted muteins of biologically active proteins |
| 12/25/1999 | CA2241576A1 Efficient non-viral transduction and culture of erythroid cells |
| 12/23/1999 | WO1999066327A2 Cartilage resorption assays |
| 12/23/1999 | WO1999066324A2 A bioluminescence resonance energy transfer (bret) system and its use |
| 12/23/1999 | WO1999066321A2 Pattern recognition proteins with lectin homology from several animal species and method to use them for measure or modulate innate resistance against bacteria and other pathogenic agents |
| 12/23/1999 | WO1999066303A2 Identification and use of differentially expressed genes and polynucleotide sequences |
| 12/23/1999 | WO1999066074A1 Vibrio vulnificus molecular probes, antibodies, and proteins |
| 12/23/1999 | WO1999066073A1 METHOD FOR SCREENING Pax4 GENE EXPRESSION POTENTIATOR AND MEDICINAL COMPOSITIONS FOR POTENTIATING Pax4 GENE EXPRESSION |
| 12/23/1999 | WO1999066064A1 Nutritional assessment by measuring mitochondrial complex activity |
| 12/23/1999 | WO1999066061A1 Nucleic acid transfer phage |
| 12/23/1999 | WO1999066057A2 Inducible promoters |
| 12/23/1999 | WO1999066054A2 Erythropoietin analog-human serum albumin fusion protein |
| 12/23/1999 | WO1999066053A1 Expression vector for use in a one-step purification protocol |
| 12/23/1999 | WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof |
| 12/23/1999 | WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | WO1999066046A1 Hiv virus mimotopes |
| 12/23/1999 | WO1999066045A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 12/23/1999 | WO1999066044A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs |
| 12/23/1999 | WO1999066043A1 Recombinant production of toxoplasma sag1 antigen |
| 12/23/1999 | WO1999066042A1 Dna sequences which code a glucose-translocator, plasmids, bacteria, yeasts and plants containing this translocator |
| 12/23/1999 | WO1999066041A1 94 human secreted proteins |
| 12/23/1999 | WO1999066040A1 Immunomodulator polypeptide, zsig57 |
| 12/23/1999 | WO1999066039A1 Tnfr-like protein with death domain |
| 12/23/1999 | WO1999066038A1 Angiostatin-binding protein |
| 12/23/1999 | WO1999066033A1 Surface targeted expression of a modified hepatitis c virus envelope protein |
| 12/23/1999 | WO1999066032A2 Cells, genetically modified with optical marker |
| 12/23/1999 | WO1999066030A1 Dap-kinase related protein |
| 12/23/1999 | WO1999066028A2 Genes for the biosynthesis of epothilones |
| 12/23/1999 | WO1999066027A1 Monoclonal antibodies that recognize antigens associated with tumor metastasis |
| 12/23/1999 | WO1999066025A2 Mtbx protein and nucleic acid molecules and uses therefor |
| 12/23/1999 | WO1999065948A1 Variant type ii tgf-beta receptor fusion proteins and methods |
| 12/23/1999 | WO1999065945A1 Force-regulated molecular recognition switches |
| 12/23/1999 | WO1999065944A1 PEPTIDE INHIBITORS OF αVβ3 AND αVβ¿5? |
| 12/23/1999 | WO1999065943A1 A method for the removal/purification of serum albumins and means for use in the method |